Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancer.
Chan Dong KimSo Hyun KimSang Hoon JungJae Hwang KimPublished in: Annals of surgical treatment and research (2019)
ATP-CRA tailored-chemotherapy has the potential to provide a survival benefit in resectable advanced CRC.